rdf:type |
|
lifeskim:mentions |
umls-concept:C0003009,
umls-concept:C0020663,
umls-concept:C0021469,
umls-concept:C0028351,
umls-concept:C0030685,
umls-concept:C0034693,
umls-concept:C0034721,
umls-concept:C0391871,
umls-concept:C0680255,
umls-concept:C1283071,
umls-concept:C1519355,
umls-concept:C1709059,
umls-concept:C1963578,
umls-concept:C2003941
|
pubmed:issue |
1
|
pubmed:dateCreated |
1993-9-2
|
pubmed:abstractText |
L-dopa is a potentiator for presynaptic beta-adrenoceptors. We studied whether L-dopa potentiates the activities of other presynaptic receptors to modulate the evoked noradrenaline (NA) release in rat hypothalamic slices. UK14304 (0.1-1 microM), a selective alpha 2-agonist, concentration-dependently inhibited NA release. Noneffective 10 pM L-dopa potentiated the UK14304-induced inhibition. This potentiation was selectively antagonized by 1 nM L-dopa methyl ester, a competitive L-dopa antagonist, while yohimbine antagonized both the inhibition by UK14304 alone and its potentiation by L-dopa. However, 10 pM L-dopa produced no effect on angiotensin II (0.1-1 nM)-induced facilitation. L-dopa potentiates activities of presynaptic beta- and alpha 2-adrenoceptors but not those of angiotensin II receptors on rat hypothalamic NA neurons.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic alpha-Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II,
http://linkedlifedata.com/resource/pubmed/chemical/Levodopa,
http://linkedlifedata.com/resource/pubmed/chemical/Norepinephrine,
http://linkedlifedata.com/resource/pubmed/chemical/Quinoxalines,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Adrenergic, alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Angiotensin,
http://linkedlifedata.com/resource/pubmed/chemical/Yohimbine,
http://linkedlifedata.com/resource/pubmed/chemical/brimonidine,
http://linkedlifedata.com/resource/pubmed/chemical/levodopa methyl ester
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0021-5198
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
119-22
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8101885-Adrenergic alpha-Agonists,
pubmed-meshheading:8101885-Angiotensin II,
pubmed-meshheading:8101885-Animals,
pubmed-meshheading:8101885-Hypothalamus,
pubmed-meshheading:8101885-Levodopa,
pubmed-meshheading:8101885-Male,
pubmed-meshheading:8101885-Norepinephrine,
pubmed-meshheading:8101885-Quinoxalines,
pubmed-meshheading:8101885-Rats,
pubmed-meshheading:8101885-Rats, Sprague-Dawley,
pubmed-meshheading:8101885-Receptors, Adrenergic, alpha,
pubmed-meshheading:8101885-Receptors, Angiotensin,
pubmed-meshheading:8101885-Synapses,
pubmed-meshheading:8101885-Yohimbine
|
pubmed:year |
1993
|
pubmed:articleTitle |
L-dopa potentiates presynaptic inhibitory alpha 2-adrenoceptor- but not facilitatory angiotensin II receptor-mediated modulation of noradrenaline release from rat hypothalamic slices.
|
pubmed:affiliation |
Department of Anaesthesiology, Yokohama City University School of Medicine, Japan.
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|